The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity
Abstract
Doxorubicin (DOX) is a chemotherapeutic drug that is utilized for solid tumors and hematologic malignancies, but its clinical application is hampered by life-threatening cardiotoxicity including cardiac dilation and heart failure. Mitochondrial quality control processes, including mitochondrial proteostasis, mitophagy, and mitochondrial dynamics and biogenesis, serve to maintain mitochondrial homeostasis in the cardiovascular system. Importantly, recent advances have unveiled a major role for defective mitochondrial quality control in the etiology of DOX cardiomyopathy. Moreover, specific interventions targeting these quality control mechanisms to preserve mitochondrial function have emerged as potential therapeutic strategies to attenuate DOX cardiotoxicity. However, clinical translation is challenging because of obscure mechanisms of action and potential adverse effects. The purpose of this review is to provide new insights regarding the role of mitochondrial quality control in the pathogenesis of DOX cardiotoxicity, and to explore promising therapeutic approaches targeting these mechanisms to aid clinical management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
Mitochondrial proteins: from biogenesis to functional networks
Pfanner, N., Warscheid, B., & Wiedemann, N. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0092-0 · Cited by 1,028
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909
Autosis and autophagic cell death: the dark side of autophagy
Liu, Y., & Levine, B. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.143 · Cited by 742
Regulated cell death pathways in doxorubicin-induced cardiotoxicity
Christidi, E., & Brunham, L. R. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03614-x · Cited by 684
Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
Wallace, K. B., Sardão, V. A., & Oliveira, P. J. (2020) · Circulation Research · doi:10.1161/circresaha.119.314681 · Cited by 599
Bordt, E. A., Clerc, P., Roelofs, B. A., Saladino, A. J., Tretter, L., Adam-Vizi, V., Cherok, E., Khalil, A., Yadava, N., Ge, S. X., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.02.020 · Cited by 591
Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S. (2013) · Nature Communications · doi:10.1038/ncomms3308 · Cited by 536
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
Henriksen, P. A. (2018) · Heart · doi:10.1136/heartjnl-2017-312103 · Cited by 536
Mitochondrial quality control in kidney injury and repair
Tang, C., Cai, J., Yin, X.-M., Weinberg, J. M., Venkatachalam, M. A., & Dong, Z. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00369-0 · Cited by 513
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Li, D. L., Wang, Z. V., Ding, G., Tan, W., Luo, X., Criollo, A., Xie, M., Jiang, N., May, H., Kyrychenko, V., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017443 · Cited by 464
Jin, Q., Li, R., Hu, N., Xin, T., Zhu, P., Hu, S., Ma, S., Zhu, H., Ren, J., & Zhou, H. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.004 · Cited by 463
Self-citationSIRT3 Deacetylates and Activates OPA1 To Regulate Mitochondrial Dynamics during Stress
Samant, S. A., Zhang, H. J., Hong, Z., Pillai, V. B., Sundaresan, N. R., Wolfgeher, D., Archer, S. L., Chan, D. C., & Gupta, M. P. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01483-13 · Cited by 446
Kong, C.-Y., Guo, Z., Song, P., Zhang, X., Yuan, Y.-P., Teng, T., Yan, L., & Tang, Q.-Z. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65258 · Cited by 412
Mitochondrial quality control mechanisms as molecular targets in cardiac ageing
Picca, A., Mankowski, R. T., Burman, J. L., Donisi, L., Kim, J.-S., Marzetti, E., & Leeuwenburgh, C. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0059-z · Cited by 387
Wenningmann, N., Knapp, M., Ande, A., Vaidya, T. R., & Ait-Oudhia, S. (2019) · Molecular Pharmacology · doi:10.1124/mol.119.115725 · Cited by 334
Kalyanaraman, B. (2020) · Redox Biology · doi:10.1016/j.redox.2019.101394 · Cited by 326
Transcription Factor GATA4 Inhibits Doxorubicin-induced Autophagy and Cardiomyocyte Death
Kobayashi, S., Volden, P., Timm, D., Mao, K., Xu, X., & Liang, Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.070037 · Cited by 284
Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury
Yang, M., Linn, B. S., Zhang, Y., & Ren, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.05.007 · Cited by 249
Self-citationRole of mitochondrial quality surveillance in myocardial infarction: From bench to bedside
Zhou, H., Ren, J., Toan, S., & Mui, D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101250 · Cited by 249
Self-citationMitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Wu, B. B., Leung, K. T., & Poon, E. N.-Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031912 · Cited by 237
Liu, D., Ma, Z., Di, S., Yang, Y., Yang, J., Xu, L., Reiter, R. J., Qiao, S., & Yuan, J. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.032 · Cited by 225
Dhingra, R., Margulets, V., Chowdhury, S. R., Thliveris, J., Jassal, D., Fernyhough, P., Dorn, G. W., & Kirshenbaum, L. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414665111 · Cited by 217
The role of mitochondrial dynamics in cardiovascular diseases
Forte, M., Schirone, L., Ameri, P., Basso, C., Catalucci, D., Modica, J., Chimenti, C., Crotti, L., Frati, G., Rubattu, S., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15068 · Cited by 216
Li, M., Sala, V., De Santis, M. C., Cimino, J., Cappello, P., Pianca, N., Di Bona, A., Margaria, J. P., Martini, M., Lazzarini, E., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030352 · Cited by 207
Beclin1-mediated interplay between autophagy and apoptosis: New understanding
Prerna, K., & Dubey, V. K. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.02.005 · Cited by 206
Mitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging
Wu, N. N., Zhang, Y., & Ren, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9825061 · Cited by 197
Self-citationAbdullah, C. S., Alam, S., Aishwarya, R., Miriyala, S., Bhuiyan, M. A. N., Panchatcharam, M., Pattillo, C. B., Orr, A. W., Sadoshima, J., Hill, J. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37862-3 · Cited by 193
Yin, J., Guo, J., Zhang, Q., Cui, L., Zhang, L., Zhang, T., Zhao, J., Li, J., Middleton, A., Carmichael, P. L., et al. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.05.001 · Cited by 192
Kubli, D. A., Quinsay, M. N., Huang, C., Lee, Y., & Gustafsson, Å. B. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00552.2008 · Cited by 187
Wang, X., Wang, X.-L., Chen, H.-L., Wu, D., Chen, J.-X., Wang, X.-X., Li, R.-L., He, J.-H., Mo, L., Cen, X., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.040 · Cited by 183
Preventing and Treating Anthracycline Cardiotoxicity: New Insights
Sawicki, K. T., Sala, V., Prever, L., Hirsch, E., Ardehali, H., & Ghigo, A. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030620-104842 · Cited by 177
Govender, J., Loos, B., Marais, E., & Engelbrecht, A. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12176 · Cited by 176
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
Deng, S., Yan, T., Jendrny, C., Nemecek, A., Vincetic, M., Gödtel-Armbrust, U., & Wojnowski, L. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-842 · Cited by 176
Hao, E., Mukhopadhyay, P., Cao, Z., Erdélyi, K., Holovac, E., Liaudet, L., Lee, W.-S., Haskó, G., Mechoulam, R., & Pacher, P. (2015) · Molecular Medicine · doi:10.2119/molmed.2014.00261 · Cited by 176
Zilinyi, R., Czompa, A., Czegledi, A., Gajtko, A., Pituk, D., Lekli, I., & Tosaki, A. (2018) · Molecules · doi:10.3390/molecules23051184 · Cited by 175
Doxorubicin‐induced cardiomyocyte death is mediated by unchecked mitochondrial fission and mitophagy
Catanzaro, M. P., Weiner, A., Kaminaris, A., Li, C., Cai, F., Zhao, F., Kobayashi, S., Kobayashi, T., Huang, Y., Sesaki, H., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802663r · Cited by 174
Heme oxygenase-1 regulates mitochondrial quality control in the heart
Hull, T. D., Boddu, R., Guo, L., Tisher, C. C., Traylor, A. M., Patel, B., Joseph, R., Prabhu, S. D., Suliman, H. B., Piantadosi, C. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85817 · Cited by 168
Liang, X., Wang, S., Wang, L., Ceylan, A. F., Ren, J., & Zhang, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104846 · Cited by 158
Self-citationBnip3 mediates doxorubicin-induced cardiomyocyte pyroptosis via caspase-3/GSDME
Zheng, X., Zhong, T., Ma, Y., Wan, X., Qin, A., Yao, B.-F., Zou, H., Song, Y., & Yin, D. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117186 · Cited by 151
Role of acetylation in doxorubicin-induced cardiotoxicity
Li, D., Yang, Y., Wang, S., He, X., Liu, M., Bai, B., Tian, C., Sun, R., Yu, T., & Chu, X. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102089 · Cited by 147
Osataphan, N., Phrommintikul, A., Chattipakorn, S. C., & Chattipakorn, N. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15305 · Cited by 146
Xia, Y., Chen, Z., Chen, A., Fu, M., Dong, Z., Hu, K., Yang, X., Zou, Y., Sun, A., Qian, J., et al. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.06.003 · Cited by 143
Cytosolic Events in the Biogenesis of Mitochondrial Proteins
Bykov, Y. S., Rapaport, D., Herrmann, J. M., & Schuldiner, M. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.04.001 · Cited by 143
Bartlett, J. J., Trivedi, P. C., Yeung, P. K. F., Kienesberger, P. C., & Pulinilkunnil, T. (2016) · Biochemical Journal · doi:10.1042/bcj20160385 · Cited by 139
Gharanei, M., Hussain, A., Janneh, O., & Maddock, H. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077713 · Cited by 136
Xu, Z., Li, C., Liu, Q.-L., Li, P., & Yang, H. Q. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113658 · Cited by 134
Dolinsky, V. W., Rogan, K. J., Sung, M. M., Zordoky, B. N., Haykowsky, M. J., Young, M. E., Jones, L. W., & Dyck, J. R. B. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00044.2013 · Cited by 133
Mitofusin 1 Is Negatively Regulated by MicroRNA 140 in Cardiomyocyte Apoptosis
Li, J., Li, Y.-Z., Jiao, J., Wang, J.-X., Li, Y.-R., Qin, D.-N., & Li, P.-F. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00774-13 · Cited by 129
Kobashigawa, L. C., Xu, Y. C., Padbury, J. F., Tseng, Y., & Yano, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104888 · Cited by 127
Yarmohammadi, F., Rezaee, R., Hayes, A. W., & Karimi, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105383 · Cited by 126
Roca-Alonso, L., Castellano, L., Mills, A. M., Dabrowska, A. F., Sikkel, M. B., Pellegrino, L., Jacob, J., Frampton, A. E., Krell, J., Coombes, R. C., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.89 · Cited by 123
Wang, J.-X., Zhang, X.-J., Feng, C., Sun, T., Wang, K., Wang, Y., Zhou, L.-Y., & Li, P.-F. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.41 · Cited by 120
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
Xu, H., Yu, W., Sun, S., Li, C., Zhang, Y., & Ren, J. T. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00113 · Cited by 120
Self-citationPolyphenols as Caloric Restriction Mimetics Regulating Mitochondrial Biogenesis and Mitophagy
Davinelli, S., De Stefani, D., De Vivo, I., & Scapagnini, G. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.02.011 · Cited by 117
Dhingra, A., Jayas, R., Afshar, P., Guberman, M., Maddaford, G. G., Gerstein, J., Lieberman, B., Nepon, H., Margulets, V., Dhingra, R., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.08.010 · Cited by 108
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
Huang, J., Wu, R., Chen, L., Yang, Z., Yan, D., & Li, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.811406 · Cited by 108
atg7 -Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Wang, Y., Lu, X., Wang, X., Qiu, Q., Zhu, P., Ma, L., Ma, X., Herrmann, J., Lin, X., Wang, W., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319104 · Cited by 106
Mitophagy Receptors and Mediators: Therapeutic Targets in the Management of Cardiovascular Ageing
Ajoolabady, A., Aslkhodapasandhokmabad, H., Aghanejad, A., Zhang, Y., & Ren, J. T. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101129 · Cited by 104
Self-citationDing, M., Shi, R., Cheng, S., Li, M., De, D., Liu, C., Gu, X., Li, J., Zhang, S., Jia, M., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102311 · Cited by 103
Wang, P., Wang, L., Lü, J., Hu, Y., Wang, Q., Li, Z., Cai, S., Liang, L., Guo, K., Xie, J., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.06.005 · Cited by 102
Self-citationMitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
Schirone, L., D’Ambrosio, L., Forte, M., Genovese, R., Schiavon, S., Spinosa, G., Iacovone, G., Valenti, V., Frati, G., & Sciarretta, S. (2022) · Cells · doi:10.3390/cells11132000 · Cited by 102
The role of melatonin on doxorubicin-induced cardiotoxicity: A systematic review
Najafi, M., Shayesteh, M. R. H., Mortezaee, K., Farhood, B., & Haghi‐Aminjan, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117173 · Cited by 100
Arinno, A., Maneechote, C., Khuanjing, T., Ongnok, B., Prathumsap, N., Chunchai, T., Arunsak, B., Kerdphoo, S., Shinlapawittayatorn, K., Chattipakorn, S. C., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114743 · Cited by 98
Zhou, H., Wang, J., Hu, S., Zhu, H., Toan, S., & Ren, J. T. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27308 · Cited by 96
Self-citationCui, L., Guo, J., Zhang, Q., Yin, J., Li, J., Zhou, W. J., Zhang, T., Yuan, H., Zhao, J., Zhang, L., et al. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.04.018 · Cited by 91
Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts
Coelho, A. R., Martins, T. R., Couto, R., Deus, C. M., Pereira, C. V., Simões, R. F., Rizvanov, A. A., Silva, F. S. G., Cunha‐Oliveira, T., Oliveira, P. J., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.030 · Cited by 80
Khuanjing, T., Ongnok, B., Maneechote, C., Siri‐Angkul, N., Prathumsap, N., Arinno, A., Chunchai, T., Arunsak, B., Chattipakorn, S. C., & Chattipakorn, N. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105882 · Cited by 76
Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2
Tang, H., Tao, A., Song, J. T., Liu, Q., Wang, H., & Tao, R. X. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.05.006 · Cited by 72
Marechal, X., Montaigne, D., Marciniak, C., Marchetti, P., Hassoun, S. M., Beauvillain, J. C., Lancel, S., & Nevière, R. (2011) · Clinical Science · doi:10.1042/cs20110069 · Cited by 69
Wu, L., Sowers, J. R., Zhang, Y., & Ren, J. T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac080 · Cited by 68
Self-citationExercise and Doxorubicin Treatment Modulate Cardiac Mitochondrial Quality Control Signaling
Marques‐Aleixo, I., Alves, E. S., Torrella, J. R., Oliveira, P. J., Magalhães, J., & Ascensão, A. A. M. R. (2017) · Cardiovascular Toxicology · doi:10.1007/s12012-017-9412-4 · Cited by 66
Guo, Q., Guo, J., Yang, R., Peng, H., Zhao, J., Li, L., & Peng, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/151972 · Cited by 63
Du, Q., Zhu, B., Zhai, Q., et al. (2017) · PubMed · Cited by 62
Guo, J., Guo, Q., Fang, H., Lei, L., Zhang, T., Zhao, J., & Peng, S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.017 · Cited by 59
Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts
Mancilla, T. R., Davis, L. R., & Aune, G. J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238856 · Cited by 54
HMGB1 contributes to adriamycin-induced cardiotoxicity via up-regulating autophagy
Luo, P., Zhu, Y., Chen, M., Yan, H., Yang, B., Yang, X., & He, Q. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.034 · Cited by 53
Novel Therapeutics for Anthracycline Induced Cardiotoxicity
Vuong, J. T., Stein-Merlob, A. F., Cheng, R. K.-H., & Yang, E. H. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.863314 · Cited by 53
Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity
Pizarro, M., Troncoso, R., Martínez, G. J., Chiong, M., Castro, P., & Lavandero, S. (2016) · Toxicology · doi:10.1016/j.tox.2016.09.011 · Cited by 48
Melatonin attenuates doxorubicin‐induced cardiotoxicity through preservation of YAP expression
Li, H., Wang, C., Sun, P., Liu, D., Du, G., & Tian, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15057 · Cited by 46
Aung, L. H. H., Li, R., Prabhakar, B. S., & Li, P. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13250 · Cited by 44
The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy
Marques‐Aleixo, I., Alves, E. S., Oliveira, P. J., Moreira, P. I., Magalhães, J., & Ascensão, A. A. M. R. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.01.002 · Cited by 44
Yang, G., Song, M., Hoang, D. H., Tran, Q. H., Choe, W., Kang, I., Kim, S. S., & Ha, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00541-3 · Cited by 44
Deus, C. M., Zehowski, C., Nordgren, K. K. S., Wallace, K. B., Skildum, A. J., & Oliveira, P. J. (2015) · Toxicology · doi:10.1016/j.tox.2015.05.001 · Cited by 39
Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
Li, W., Wang, X., Liu, T., Zhang, Q., Cao, J., Jiang, Y., Sun, Q., Li, C., Wang, W., & Wang, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.813370 · Cited by 36
Zhuang, X., Sun, X., Zhou, H., Zhang, S., Zhong, X., Xu, X., Guo, Y., Xiong, Z., Liu, M., Lin, Y., et al. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111442 · Cited by 34
Wang, H., Wang, H., Liang, E., Zhou, L., Zhan-ling, D., Liang, P., Qi-fang, W., & Yang, M. (2017) · Oncology Letters · doi:10.3892/ol.2017.7410 · Cited by 31
Cai, W., Fujita, T., Hidaka, Y., Jin, H., Suita, K., Shigeta, M., Kiyonari, H., Umemura, M., Yokoyama, U., Sadoshima, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1787-7 · Cited by 25
Babaei-Kouchaki, S., Babapour, V., Panahi, N., & Badalzadeh, R. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01818-0 · Cited by 18
Cited by
Feng, C., Wang, Y., Xu, J., Zheng, Y., Zhou, W., Wang, Y., & Luo, C. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121582 · Cited by 317
PANoptosis: Mechanisms, biology, and role in disease
Sun, X., Yang, Y., Meng, X., Li, J., Liu, X., & Liu, H. (2024) · Immunological Reviews · doi:10.1111/imr.13279 · Cited by 305
Metadata
- Authors
- Wu, L., Wang, L., Du, Y., Zhang, Y., & Ren, J.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 44
- Issue
- 1
- Pages
- 34-49
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W4309020803
- Cited by
- 257
- References
- 93
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.